There are currently no known outstanding effects for the The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Section 13.
13. In regulation 31A(4)(b) M1—
(a)for “applicable”, substitute “ relevant ”; and
(b)for the words “Directive 2001/83/EC” to the end, substitute “ these Regulations ”.
Commencement Information
I1Reg. 13 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1
Marginal Citations
M1Regulation 31A was inserted by S.I. 2006/1928.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
